A novel curcumin analogue, C66, prevents diabetic nephropathy by altering both miR-200a and miR-21 https://t.co/2vhlNEu2Iy
RT @DiabetologiaJnl: A novel curcumin analogue, C66, prevents diabetic nephropathy by altering both miR-200a and miR-21 https://t.co/2vhlNE…
RT @DiabetologiaJnl: A novel curcumin analogue, C66, prevents diabetic nephropathy by altering both miR-200a and miR-21 https://t.co/2vhlNE…
A novel curcumin analogue, C66, prevents diabetic nephropathy by altering both miR-200a and miR-21 https://t.co/2vhlNEu2Iy
A novel curcumin analogue, C66, prevents diabetic nephropathy by altering both miR-200a and miR-21 https://t.co/2vhlNEu2Iy
RT @intrepidbio: "C66 ameliorates diabetic nephropathy in mice... via increase in miR-200a & inhibiting miR-21 https://t.co/cIUlvmUFzU;" @u…
"C66 ameliorates diabetic nephropathy in mice... via increase in miR-200a & inhibiting miR-21 https://t.co/cIUlvmUFzU;" @uofl. @miRagenCEO